Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Placebo-Control Strategy After EUA Remains Big Question For Pfizer/BioNTech COVID-19 Vaccine

Dec 09 2020

• By Derrick Gingery

Related Content

After EUA, COVID Vaccine Sponsors Need Plans For Continuing Trials

Oct 07 2020

CBER Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., Marks Says

Dec 04 2020

Moderna Gets To Watch And Learn From Pfizer’s COVID-19 Vaccine Advisory Committee

Dec 01 2020

Vaccine Distribution Priorities To Rely On Governors, Not ACIP, HHS Secretary Azar Says

Nov 24 2020

COVID-19 Vaccines: Placebo Crossover May Depend Upon Number Of Doses, Allocation Strategy

Nov 20 2020

Health Care Personnel, Long-Term Care Residents Should Get COVID-19 Vaccine First, ACIP Votes

Dec 02 2020

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Additional Topics

United States Advisory Committees Coronavirus COVID-19 Regulation FDA Review Pathway Vaccines BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window